Abstract Details
|
Hisatomo Kowa, MD, PhD
(Kobe Univ Graduate School of Health Sciences)
PRESENTER |
No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Jonathan W. Mink, MD, PhD, FÂ鶹´«Ã½Ó³» | The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. The institution of Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. Dr. Mink has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³». The institution of Dr. Mink has received research support from Neurogene. The institution of Dr. Mink has received research support from NIH. Dr. Mink has received publishing royalties from a publication relating to health care. Dr. Mink has received personal compensation in the range of $500-$4,999 for serving as a Member, Study Section with NINDS. |
| Takashi Matsukawa, MD | No disclosure on file |
| Shoji Tsuji, MD, PhD (University of Tokyo) | The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd.. |
| Fumio Kanda, MD, PhD, FÂ鶹´«Ã½Ó³» (Kusunoki Neurology Clinic) | No disclosure on file |
| No disclosure on file |